GLOBUS MEDICAL, INC. Pre-Tax Income
GLOBUS MEDICAL, INC. (GMED) reported Pre-Tax Income of $189.82 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Pre-tax Income
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest · last filed 2026-08-06
- GLOBUS MEDICAL, INC. income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2026-06-30 was $189.82M, a 0.87% increase year-over-year.
- GLOBUS MEDICAL, INC. income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2026-03-31 was $157.07M, a 51.52% increase year-over-year.
- GLOBUS MEDICAL, INC. income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2025-12-31 was $169.23M, a 586.07% increase year-over-year.
- GLOBUS MEDICAL, INC. income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2025-09-30 was $143.99M, a 152.48% increase year-over-year.
- GLOBUS MEDICAL, INC. income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2025 was $605.07M, a 401.21% increase from fiscal 2024.
- GLOBUS MEDICAL, INC. income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2024 was $120.72M, a 27.01% decline from fiscal 2023.
- GLOBUS MEDICAL, INC. income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2023 was $165.39M, a 31.94% decline from fiscal 2022.
- GLOBUS MEDICAL, INC. income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2022 was $243.02M, a 34.71% increase from fiscal 2021.
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 3 month | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 6 month | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 9 month | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 12 month |
|---|---|---|---|---|
| 2026-06-30 | $189.82M 10-Q · filed 2026-08-06 | $346.89M 10-Q · filed 2026-08-06 | $516.12M derived: sum of 3 quarters · filed 2026-08-06 | $660.12M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $157.07M 10-Q · filed 2026-05-07 | $326.31M derived: sum of 2 quarters · filed 2026-05-07 | $470.30M derived: sum of 3 quarters · filed 2026-05-07 | $658.47M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $169.23M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $313.23M derived: sum of 2 quarters · filed 2026-02-24 | $501.40M derived: sum of 3 quarters · filed 2026-08-06 | $605.07M 10-K · filed 2026-02-24 |
| 2025-09-30 | $143.99M 10-Q · filed 2025-11-06 | $332.17M derived: sum of 2 quarters · filed 2026-08-06 | $435.83M 10-Q · filed 2025-11-06 | $460.50M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $188.17M 10-Q · filed 2026-08-06 | $291.84M 10-Q · filed 2026-08-06 | $316.51M derived: sum of 3 quarters · filed 2026-08-06 | $373.54M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $103.67M 10-Q · filed 2026-05-07 | $128.34M derived: sum of 2 quarters · filed 2026-05-07 | $185.37M derived: sum of 3 quarters · filed 2026-05-07 | $232.95M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $24.67M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $81.70M derived: sum of 2 quarters · filed 2026-02-24 | $129.28M derived: sum of 3 quarters · filed 2026-02-24 | $120.72M 10-K · filed 2026-02-24 |
| 2024-09-30 | $57.03M 10-Q · filed 2025-11-06 | $104.61M derived: sum of 2 quarters · filed 2025-11-06 | $96.06M 10-Q · filed 2025-11-06 | $121.05M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-06-30 | $47.58M 10-Q · filed 2025-08-07 | $39.02M 10-Q · filed 2025-08-07 | $64.02M derived: sum of 3 quarters · filed 2026-02-24 | $66.55M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-03-31 | -$8.56M 10-Q · filed 2025-05-08 | $16.44M derived: sum of 2 quarters · filed 2026-02-24 | $18.97M derived: sum of 3 quarters · filed 2026-02-24 | $93.64M derived: sum of 4 quarters · filed 2026-02-24 |
| 2023-12-31 | $24.99M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $27.53M derived: sum of 2 quarters · filed 2026-02-24 | $102.20M derived: sum of 3 quarters · filed 2026-02-24 | $165.39M 10-K · filed 2026-02-24 |
| 2023-09-30 | $2.54M 10-Q · filed 2024-11-05 | $77.21M derived: sum of 2 quarters · filed 2024-11-05 | $140.40M 10-Q · filed 2024-11-05 | $202.51M derived: sum of 4 quarters · filed 2025-02-20 |
| 2023-06-30 | $74.67M 10-Q · filed 2024-08-06 | $137.86M 10-Q · filed 2024-08-06 | $199.98M derived: sum of 3 quarters · filed 2025-02-20 | $261.44M derived: sum of 4 quarters · filed 2025-02-20 |
| 2023-03-31 | $63.19M 10-Q · filed 2024-05-07 | $125.31M derived: sum of 2 quarters · filed 2025-02-20 | $186.77M derived: sum of 3 quarters · filed 2025-02-20 | $257.31M derived: sum of 4 quarters · filed 2025-02-20 |
| 2022-12-31 | $62.12M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | $123.58M derived: sum of 2 quarters · filed 2025-02-20 | $194.12M derived: sum of 3 quarters · filed 2025-02-20 | $243.02M 10-K · filed 2025-02-20 |
| 2022-09-30 | $61.47M 10-Q · filed 2023-11-07 | $132.00M derived: sum of 2 quarters · filed 2023-11-07 | $180.90M 10-Q · filed 2023-11-07 | $200.73M derived: sum of 4 quarters · filed 2024-02-21 |
| 2022-06-30 | $70.54M 10-Q · filed 2023-08-03 | $119.44M 10-Q · filed 2023-08-03 | $139.27M derived: sum of 3 quarters · filed 2024-02-21 | $193.72M derived: sum of 4 quarters · filed 2024-02-21 |
| 2022-03-31 | $48.90M 10-Q · filed 2023-05-04 | $68.73M derived: sum of 2 quarters · filed 2024-02-21 | $123.18M derived: sum of 3 quarters · filed 2024-02-21 | $172.11M derived: sum of 4 quarters · filed 2024-02-21 |
| 2021-12-31 | $19.83M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | $74.28M derived: sum of 2 quarters · filed 2024-02-21 | $123.21M derived: sum of 3 quarters · filed 2024-02-21 | $180.41M 10-K · filed 2024-02-21 |
| 2021-09-30 | $54.45M 10-Q · filed 2022-11-08 | $103.39M derived: sum of 2 quarters · filed 2022-11-08 | $160.58M 10-Q · filed 2022-11-08 | $222.79M derived: sum of 4 quarters · filed 2023-02-21 |
| 2021-06-30 | $48.93M 10-Q · filed 2022-08-04 | $106.13M 10-Q · filed 2022-08-04 | $168.34M derived: sum of 3 quarters · filed 2023-02-21 | $221.47M derived: sum of 4 quarters · filed 2023-02-21 |
| 2021-03-31 | $57.19M 10-Q · filed 2022-05-10 | $119.41M derived: sum of 2 quarters · filed 2023-02-21 | $172.54M derived: sum of 3 quarters · filed 2023-02-21 | |
| 2020-12-31 | $62.21M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-21 | $115.34M derived: sum of 2 quarters · filed 2023-02-21 | $125.90M 10-K · filed 2023-02-21 | |
| 2020-09-30 | $53.13M 10-Q · filed 2021-11-04 | $63.69M 10-Q · filed 2021-11-04 | ||
| 2019-12-31 | $189.95M 10-K · filed 2022-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B |